BACKGROUND
Tacrolimus is the cornerstone of immunosuppressive treatment after kidney transplantation. Its application requires therapeutic drug monitoring, which is routinely performed by assessment of whole blood tacrolimus concentrations (WBTC) that largely comprises a pharmacologically inactive fraction. Monitoring...
J. Jonker, J. C. van den Born, D. Kremer et al.· American Society of Nephrolo...· 0 citations
This validated LC-MS/MS method allows simultaneous analysis of multiple anti-TB drugs in plasma, serum, and saliva, facilitating clinical and research applications and demonstrated linearity, selectivity, and minimal carry-over.
M. Bolhuis, E. M. Jongedijk, O. Akkerman et al.· Therapeutic Drug Monitoring· 0 citations
Target attainment was suboptimal for most TKIs, supporting the need for TDM-guided optimisation and individualised dosing, and Associations between TKI exposure and renal, hepatic, and haematological parameters further support personalised treatment strategies.
Zaid N. Al Shirity, P. Mian, A. Dontje et al.· Clinical Pharmacokinetics· 0 citations
Actionable pharmacogenetic variants are highly prevalent in alloHCT-recipients and future studies should investigate whether genotype-guided drug selection and dosing could improve outcomes in alloHCT recipients.
Lea P. A. Timmann, Pauline Lanting, L. Morsink et al.· Hemato· 0 citations
A cryopreservable and scalable workflow is developed to generate hiPSC-derived hepatic organoids that can be directly matured to either static HLOs or LoC systems, enabling matched comparison of both platforms and establishing a robust hiPSC-derived LoC platform.
Isabel Tamargo-Rubio, T. Krempel, Victoria Palasantzas et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.